FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

732936001: Tablet (unit of presentation)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3498396015 Tablet (unit of presentation) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3498397012 Tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
799361000241114 comprimé fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
3357851001000118 Tablette de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tablet (unit of presentation) Is a Unit of presentation (unit of presentation) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Etoricoxib 90 mg and thiocolchicoside 8 mg conventional release and prolonged-release oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Etoricoxib 90 mg and thiocolchicoside 8 mg conventional release and prolonged-release oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Etoricoxib 90 mg and thiocolchicoside 8 mg conventional release and prolonged-release oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 2
Sodium valproate 133 mg and valproic acid 58 mg prolonged-release oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Sodium valproate 133 mg and valproic acid 58 mg prolonged-release oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Sodium valproate 133 mg and valproic acid 58 mg prolonged-release oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 2
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 2
Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely ritonavir 25 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely ritonavir 25 milligram/1 each conventional release oral tablet (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Ritonavir 50 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Ritonavir 50 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Retinol (as retinol palmitate) 10000 unit oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Retinol (as retinol palmitate) 10000 unit oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Ruxolitinib (as ruxolitinib phosphate) 25 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Ruxolitinib (as ruxolitinib phosphate) 25 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely glimepiride 2 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely glimepiride 2 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely glimepiride 2 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely glimepiride 4 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely glimepiride 4 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely glimepiride 4 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 2
Metformin hydrochloride 500 mg and pioglitazone (as pioglitazone hydrochloride) 15 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Metformin hydrochloride 500 mg and pioglitazone (as pioglitazone hydrochloride) 15 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Metformin hydrochloride 500 mg and pioglitazone (as pioglitazone hydrochloride) 15 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely glimepiride 4 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely glimepiride 4 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely glimepiride 4 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 2
Glimepiride 2 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Glimepiride 2 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Glimepiride 2 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 2
Glimepiride 1 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Glimepiride 1 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Glimepiride 1 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely glimepiride 2 milligram and rosiglitazone (as rosiglitazone maleate) 8 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely glimepiride 2 milligram and rosiglitazone (as rosiglitazone maleate) 8 milligram/1 each conventional release oral tablet (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely glimepiride 2 milligram and rosiglitazone (as rosiglitazone maleate) 8 milligram/1 each conventional release oral tablet (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 2
Glimepiride 4 mg and rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Glimepiride 4 mg and rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Glimepiride 4 mg and rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 2
Metformin hydrochloride 500 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Metformin hydrochloride 500 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Metformin hydrochloride 500 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely metformin hydrochloride 850 milligram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely metformin hydrochloride 850 milligram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely metformin hydrochloride 850 milligram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely metformin hydrochloride 1 gram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely metformin hydrochloride 1 gram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely metformin hydrochloride 1 gram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 2
Alogliptin (as alogliptin benzoate) 6.25 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Alogliptin (as alogliptin benzoate) 6.25 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Alogliptin (as alogliptin benzoate) 12.5 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Alogliptin (as alogliptin benzoate) 12.5 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Alogliptin (as alogliptin benzoate) 25 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Alogliptin (as alogliptin benzoate) 25 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 850 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 850 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 850 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 2
Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 1 g oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 1 g oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 1 g oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 2
Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 500 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 500 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 500 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely ropinirole (as ropinirole hydrochloride) 4 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely ropinirole (as ropinirole hydrochloride) 4 milligram/1 each conventional release oral tablet (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely ropinirole (as ropinirole hydrochloride) 3 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely ropinirole (as ropinirole hydrochloride) 3 milligram/1 each conventional release oral tablet (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Ropinirole (as ropinirole hydrochloride) 500 microgram oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Ropinirole (as ropinirole hydrochloride) 500 microgram oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely quetiapine (as quetiapine fumarate) 400 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely quetiapine (as quetiapine fumarate) 400 milligram/1 each conventional release oral tablet (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely quetiapine (as quetiapine fumarate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely quetiapine (as quetiapine fumarate) 50 milligram/1 each conventional release oral tablet (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely quinagolide (as quinagolide hydrochloride) 25 microgram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely quinagolide (as quinagolide hydrochloride) 25 microgram/1 each conventional release oral tablet (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Quinagolide (as quinagolide hydrochloride) 50 microgram oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Quinagolide (as quinagolide hydrochloride) 50 microgram oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely hydrochlorothiazide 25 milligram and quinapril (as quinapril hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely hydrochlorothiazide 25 milligram and quinapril (as quinapril hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely hydrochlorothiazide 25 milligram and quinapril (as quinapril hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely hydrochlorothiazide 12.5 milligram and quinapril (as quinapril hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely hydrochlorothiazide 12.5 milligram and quinapril (as quinapril hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely hydrochlorothiazide 12.5 milligram and quinapril (as quinapril hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 2
Naratriptan (as naratriptan hydrochloride) 1 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Naratriptan (as naratriptan hydrochloride) 1 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Terazosin (as terazosin hydrochloride) 1 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Terazosin (as terazosin hydrochloride) 1 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Sertraline (as sertraline hydrochloride) 25 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Sertraline (as sertraline hydrochloride) 25 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Vardenafil (as vardenafil hydrochloride) 2.5 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Vardenafil (as vardenafil hydrochloride) 2.5 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 1
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. True Tablet (unit of presentation) Inferred relationship Some 2

Start Previous Page 78 of 87 Next End

This concept is not in any reference sets

Back to Start